Total Non-Current Liabilities

$82.99B

Quarterly · Period ending: Jun 28, 2026 · USD

Latest reported$82.99Bperiod endingJun 28, 2026

PFE Quarterly Total Non-Current Liabilities ($575.90M → $82.99B)

Quarterly total non-current liabilities

High-resolution chart · PNG

PFE total non-current liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Total Non-Current Liabilities — Quarterly (USD)
Period ending	Total Non-Current Liabilities (USD)
Jul 1, 2001	7,141,000,000
Apr 1, 2001	6,524,000,000
Dec 31, 2000	5,453,000,000
Oct 1, 2000	4,972,000,000
Jul 2, 2000	4,853,000,000
Apr 2, 2000	2,559,000,000
Dec 31, 1999	5,526,000,000
Oct 3, 1999	2,361,000,000
Jul 4, 1999	2,179,000,000
Apr 4, 1999	2,228,000,000
Dec 31, 1998	2,300,000,000
Sep 27, 1998	2,273,000,000
Jun 28, 1998	2,065,000,000
Mar 29, 1998	2,085,000,000
Dec 31, 1997	2,064,000,000
Sep 28, 1997	2,120,000,000
Jun 29, 1997	2,096,000,000
Mar 30, 1997	2,081,000,000
Dec 31, 1996	2,023,000,000
Sep 29, 1996	1,799,000,000
Jun 30, 1996	1,738,000,000
Mar 31, 1996	1,756,000,000
Dec 31, 1995	1,988,900,000
Oct 1, 1995	1,694,400,000
Jul 2, 1995	1,968,900,000
Apr 2, 1995	2,000,500,000
Dec 31, 1994	1,909,900,000
Oct 2, 1994	2,070,700,000
Jul 3, 1994	2,028,900,000
Apr 3, 1994	2,015,500,000
Dec 31, 1993	1,982,500,000
Sep 30, 1993	1,873,400,000
Jun 30, 1993	1,680,100,000
Mar 31, 1993	1,620,200,000
Dec 31, 1992	1,619,200,000
Sep 30, 1992	1,402,200,000
Jun 30, 1992	1,330,100,000
Mar 31, 1992	1,323,900,000
Dec 31, 1991	1,153,400,000
Sep 30, 1991	678,200,000
Jun 30, 1991	704,300,000
Mar 31, 1991	779,400,000
Dec 31, 1990	814,400,000
Sep 30, 1990	811,500,000
Jun 30, 1990	815,700,000
Mar 31, 1990	837,000,000
Dec 31, 1989	853,300,000
Dec 31, 1988	992,200,000
Dec 31, 1987	1,083,600,000
Dec 31, 1986	577,800,000
Dec 31, 1985	575,900,000